Cargando…
Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer
Background: Bladder cancer (BLCA) is one of the most common urinary tract malignant tumors. It is associated with poor outcomes, and its etiology and pathogenesis are not fully understood. There is great hope for immunotherapy in treating many malignant tumors; therefore, it is worthwhile to explore...
Autores principales: | Qu, GenYi, Liu, Zhengsheng, Yang, Guang, Xu, Yong, Xiang, Maolin, Tang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109062/ https://www.ncbi.nlm.nih.gov/pubmed/33888644 http://dx.doi.org/10.18632/aging.202917 |
Ejemplares similares
-
Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis
por: Xu, Ning, et al.
Publicado: (2020) -
Development of a prognostic index based on immunogenomic landscape analysis in glioma
por: Luo, Haitao, et al.
Publicado: (2021) -
An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
por: Hou, Jian, et al.
Publicado: (2022) -
Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer
por: Lin, Kang, et al.
Publicado: (2020) -
Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer
por: Lin, Peng, et al.
Publicado: (2019)